Can perimenopause cause frozen shoulder?

Yes, perimenopause is increasingly recognized as a significant risk factor for frozen shoulder, and the connection is supported by epidemiological patterns and biological reasoning. Frozen shoulder (adhesive capsulitis) is a painful condition involving progressive stiffening of the shoulder joint capsule, leading to severe restriction of movement. It is significantly more common in women, and its incidence peaks between ages 40 and 60, directly overlapping the perimenopausal window.

Estrogen supports the health and maintenance of connective tissue throughout the body, including the joint capsules that surround synovial joints. Estrogen receptors are present in shoulder joint tissues, including the synovial lining and the capsular collagen. Estrogen influences collagen synthesis, turnover, and the regulation of inflammatory activity within connective tissue structures. The shoulder capsule, which is particularly rich in collagen, appears to be vulnerable when estrogen's maintenance role is reduced or destabilized.

During perimenopause, as estrogen levels fluctuate and decline, the connective tissue in joint capsules may become more susceptible to inflammatory remodeling. The proposed mechanism for frozen shoulder involves an initial inflammatory phase in which the joint capsule becomes inflamed and thickened, followed by fibrosis (scarring), which progressively restricts movement. The estrogen withdrawal associated with perimenopause may lower the threshold for this inflammatory process in the shoulder capsule, explaining the higher incidence in perimenopausal women.

Epidemiological data supports this connection. Several studies and clinical observations have noted that frozen shoulder is substantially more prevalent in women in their late 40s and 50s compared to men of the same age and to younger women. Some data suggests that women on hormone therapy may have a lower incidence of frozen shoulder, consistent with a protective role of estrogen in capsular health, though direct randomized evidence is limited.

Frozen shoulder is also associated with diabetes mellitus, thyroid disorders, and cardiovascular disease, all of which become more common around the time of perimenopause. These comorbidities may compound the perimenopausal risk. Hypothyroidism in particular is a well-known risk factor for frozen shoulder and becomes more prevalent in women during and after perimenopause.

The clinical progression of frozen shoulder involves three overlapping phases. The freezing phase involves gradually worsening pain and the beginning of stiffness, typically lasting weeks to several months. The frozen phase involves severe stiffness with limited movement, often persisting for 6 to 18 months. Pain may be less severe in this phase than in the freezing phase. The thawing phase involves gradual return of movement over months to years. Without treatment, full natural resolution can take 2 to 3 years or longer, though many patients have residual limitation.

Early diagnosis and treatment significantly improves outcomes. Physiotherapy in the early stages, when inflammation is still active, combined with corticosteroid injections to reduce capsular inflammation, can prevent the condition from progressing to the fully frozen state. Physical therapy in the frozen phase focuses on maintaining and gradually recovering movement through specific exercises rather than forcing range through pain.

Sleeping position is important: avoiding lying directly on the affected shoulder and positioning the arm with supportive pillows reduces nighttime pain and allows better sleep quality. NSAIDs or topical anti-inflammatories provide pain management alongside physiotherapy. Thyroid function should be checked in women with frozen shoulder during perimenopause, as hypothyroidism is a modifiable and treatable contributing factor. Diabetic screening with a fasting glucose or HbA1c is also appropriate, since diabetes is one of the strongest known risk factors for frozen shoulder and its relationship with perimenopause means both conditions may co-exist and compound each other.

For cases that do not respond to conservative management, hydrodilatation (injecting fluid into the joint under imaging guidance to stretch the capsule) or shoulder arthroscopy (surgical release of the contracted capsule) are effective options.

Tracking your symptoms over time, using a tool like PeriPlan, can help you document shoulder stiffness and pain changes alongside your overall perimenopausal symptom burden, providing context for your care team.

When to talk to your doctor:

Seek evaluation promptly if you notice progressive shoulder stiffness, difficulty reaching behind your back or overhead, or pain that is disturbing sleep. Early intervention is significantly more effective than waiting. Do not assume shoulder pain during perimenopause is simply muscle tension without a proper assessment. Early physiotherapy and possibly corticosteroid injection in the freezing phase may prevent significant loss of function.

This content is for informational purposes only and does not replace medical advice. Always consult your healthcare provider about your specific situation.